Lixin Qiao

Person

Tewksbury, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Ligand-directed covalent modification of protein
- Patent number 11,542,492
- Issue date Jan 3, 2023
- Celgene CAR LLC
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 11,351,168
- Issue date Jun 7, 2022
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that enhance Atoh1 expression
- Patent number 11,160,808
- Issue date Nov 2, 2021
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,098,061
- Issue date Aug 24, 2021
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2,4-diaminopyrimidines as kinase inhibitors
- Patent number 10,828,300
- Issue date Nov 10, 2020
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase conjugates and inhibitors
- Patent number 10,662,195
- Issue date May 26, 2020
- Celgene CAR LLC
- Juswinder Singh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 10,596,172
- Issue date Mar 24, 2020
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that enhance Atoh1 expression
- Patent number 10,406,163
- Issue date Sep 10, 2019
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,138,256
- Issue date Nov 27, 2018
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 10,010,548
- Issue date Jul 3, 2018
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2,4-diaminopyrimidines as kinase inhibitors
- Patent number 9,987,276
- Issue date Jun 5, 2018
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ERK inhibitors and uses thereof
- Patent number 9,980,964
- Issue date May 29, 2018
- Celgene CAR LLC
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ERK inhibitors and uses thereof
- Patent number 9,796,700
- Issue date Oct 24, 2017
- Celgene CAR LLC
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 9,694,086
- Issue date Jul 4, 2017
- Celgene CAR LLC
- Russell C. Petter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 9,676,785
- Issue date Jun 13, 2017
- Celgene CAR LLC
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ERK inhibitors and uses thereof
- Patent number 9,561,228
- Issue date Feb 7, 2017
- Celgene Avilomics Research, Inc.
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase conjugates and inhibitors
- Patent number 9,556,426
- Issue date Jan 31, 2017
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ERK inhibitors and uses thereof
- Patent number 9,504,686
- Issue date Nov 29, 2016
- Celgene Avilomics Research, Inc.
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that enhance Atoh1 expression
- Patent number 9,433,610
- Issue date Sep 6, 2016
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 9,422,333
- Issue date Aug 23, 2016
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,4-disubstituted pyrimidines as kinase inhibitors
- Patent number 9,409,921
- Issue date Aug 9, 2016
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2,4-diaminopyrimidines as kinase inhibitors
- Patent number 9,296,737
- Issue date Mar 29, 2016
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2,4-diaminopyrimidines as kinase inhibitors
- Patent number 9,212,181
- Issue date Dec 15, 2015
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 9,163,061
- Issue date Oct 20, 2015
- Celgene Avilomics Research, Inc.
- Russell C. Petter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ERK inhibitors and uses thereof
- Patent number 9,145,387
- Issue date Sep 29, 2015
- Celgene Avilomics Research, Inc.
- Nadia Haq
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 8,980,935
- Issue date Mar 17, 2015
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting Eph B-3 kinase
- Patent number 8,927,545
- Issue date Jan 6, 2015
- Duke University
- Lixin Qiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that enhance Atoh1 expression
- Patent number 8,859,597
- Issue date Oct 14, 2014
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 8,778,877
- Issue date Jul 15, 2014
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV protease inhibitors and uses thereof
- Patent number 8,741,837
- Issue date Jun 3, 2014
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20240190890
- Publication date Jun 13, 2024
- Bristol-Myers Squibb Company
- Xirui Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds that Enhance Atoh1 Expression
- Publication number 20200179394
- Publication date Jun 11, 2020
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190192512
- Publication date Jun 27, 2019
- Celgene CAR LLC
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20190135835
- Publication date May 9, 2019
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190117650
- Publication date Apr 25, 2019
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ligand-Directed Covalent Modification of Protein
- Publication number 20170218353
- Publication date Aug 3, 2017
- Celgene CAR LLC
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20170210729
- Publication date Jul 27, 2017
- Celgene CAR LLC
- Nadia Haq
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Protein Kinase Conjugates and Inhibitors
- Publication number 20170174691
- Publication date Jun 22, 2017
- CELGENE AVILOMICS RESEARCH, INC.
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20170137406
- Publication date May 18, 2017
- Celgene Avilomics Research, Inc.
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20170137463
- Publication date May 18, 2017
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20170100397
- Publication date Apr 13, 2017
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds That Enhance ATOH1 Expression
- Publication number 20170095481
- Publication date Apr 6, 2017
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20160326216
- Publication date Nov 10, 2016
- Celgene Avilomics Research, Inc.
- Deqiang Niu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20160303121
- Publication date Oct 20, 2016
- Celgene Avilomics Research, Inc.
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20160243249
- Publication date Aug 25, 2016
- CELGENE AVILOMICS RESEARCH, INC.
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20160235805
- Publication date Aug 18, 2016
- CELGENE AVILOMICS RESEARCH, INC.
- Russell C. Petter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20160082008
- Publication date Mar 24, 2016
- CELGENE AVILOMICS RESEARCH, INC.
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20160002176
- Publication date Jan 7, 2016
- CELGENE AVILOMICS RESEARCH, INC.
- Nadia Haq
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20150376208
- Publication date Dec 31, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- Matthew David ALEXANDER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
- Publication number 20150216865
- Publication date Aug 6, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- William Frederick Westlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20150175657
- Publication date Jun 25, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- Deqiang Niu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds that Enhance Atoh1 Expression
- Publication number 20150157607
- Publication date Jun 11, 2015
- Massachusetts Eye and Ear Infirmary
- Albert Edge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20150031106
- Publication date Jan 29, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- Deqiang Niu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20140323465
- Publication date Oct 30, 2014
- Deqiang Niu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK INHIBITORS AND USES THEREOF
- Publication number 20140228322
- Publication date Aug 14, 2014
- CELGENE AVILOMICS RESEARCH, INC.
- Nadia Haq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20140213574
- Publication date Jul 31, 2014
- CELGENE AVILOMICS RESEARCH, INC.
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20130338062
- Publication date Dec 19, 2013
- CELGENE AVILOMICS RESEARCH, INC.
- Deqiang Niu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20130165462
- Publication date Jun 27, 2013
- CELGENE AVILOMICS RESEARCH, INC.
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV PROTEASE INHIBITORS AND USES THEREOF
- Publication number 20130131105
- Publication date May 23, 2013
- CELGENE AVILOMICS RESEARCH, INC.
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20130072469
- Publication date Mar 21, 2013
- CELGENE AVILOMICS RESEARCH, INC.
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Ligand-directed covalent modification of protein

2,4-disubstituted pyrimidines useful as kinase inhibitors

Compounds that enhance Atoh1 expression

MK2 inhibitors and uses thereof

Substituted 2,4-diaminopyrimidines as kinase inhibitors

Protein kinase conjugates and inhibitors

2,4-disubstituted pyrimidines useful as kinase inhibitors

Compounds that enhance Atoh1 expression

MK2 inhibitors and uses thereof

2,4-disubstituted pyrimidines useful as kinase inhibitors

Substituted 2,4-diaminopyrimidines as kinase inhibitors

ERK inhibitors and uses thereof

ERK inhibitors and uses thereof

HCV protease inhibitors and uses thereof

HCV protease inhibitors and uses thereof

ERK inhibitors and uses thereof

Protein kinase conjugates and inhibitors

ERK inhibitors and uses thereof

Compounds that enhance Atoh1 expression

HCV protease inhibitors and uses thereof

2,4-disubstituted pyrimidines as kinase inhibitors

Substituted 2,4-diaminopyrimidines as kinase inhibitors

Substituted 2,4-diaminopyrimidines as kinase inhibitors

HCV protease inhibitors and uses thereof

ERK inhibitors and uses thereof

HCV protease inhibitors and uses thereof

Inhibiting Eph B-3 kinase

Compounds that enhance Atoh1 expression

HCV protease inhibitors and uses thereof

HCV protease inhibitors and uses thereof

Patents Applicationslast 30 patents

MK2 INHIBITORS AND USES THEREOF

Compounds that Enhance Atoh1 Expression

HETEROARYL COMPOUNDS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

Ligand-Directed Covalent Modification of Protein

ERK INHIBITORS AND USES THEREOF

Protein Kinase Conjugates and Inhibitors

ERK INHIBITORS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

Compounds That Enhance ATOH1 Expression

HCV PROTEASE INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

ERK INHIBITORS AND USES THEREOF

ERK INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER

HCV PROTEASE INHIBITORS AND USES THEREOF

Compounds that Enhance Atoh1 Expression

HCV PROTEASE INHIBITORS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

ERK INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HCV PROTEASE INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF